SAN DIEGO, October 26, 2023 – ResMed Inc. (NYSE: RMD, ASX: RMD) announced results for its
quarter ended September 30, 2023.
First Quarter 2024 Highlights
All comparisons are to the prior year period
• Revenue increased by 16% to $1.1 billion; up 15% on a constant currency basis
• Gross margin contracted 250 bps to 54.4%; non-GAAP gross margin contracted 160 bps to 56.0%
• Income from operations increased 5%; non-GAAP operating profit up 10%
• Operating cash flow of $286.3 million
• Diluted earnings per share of $1.49; non-GAAP diluted earnings per share of $1.64
Buy RMD now and get great upside returns in a year or two, page-4
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$31.90 |
Change
0.010(0.03%) |
Mkt cap ! $20.24B | |||
| Open | High | Low | Value | Volume |
| $31.99 | $31.99 | $31.85 | $1.651M | 51.69K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 339 | $31.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $31.91 | 14 | 2 |
View Market Depth
| Last trade - 10.14am 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$31.91 |
Change
0.010 ( 0.07 %) |
||||
| Open | High | Low | Volume | ||
| $31.92 | $31.93 | $31.85 | 8756 | ||
| Last updated 10.35am 14/06/2024 ? | |||||
| RMD (ASX) Chart |